Abstract
Ten-Year Follow-up of Patients with Chronic Myeloid Leukemia Treated with Nilotinib in First-Line: Final Results of the Gimema CML 0307 Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have